ZBH
42
-2
EMN
56
-2
BF.B
48
-2
ILMN
73
4
AN
50
7
SO
46
-5
L
71
2
ORCL
33
7
PYPL
52
2
PLD
30
2
BK
74
5
TAP
29
-11
ZTS
21
2
BAX
38
-12
UHS
55
3
EMR
64
5
SE
49
2
TGNA
53
-3
HAL
50
2
HD
28
-4
ZBH
42
-2
EMN
56
-2
BF.B
48
-2
ILMN
73
4
AN
50
7
SO
46
-5
L
71
2
ORCL
33
7
PYPL
52
2
PLD
30
2
BK
74
5
TAP
29
-11
ZTS
21
2
BAX
38
-12
UHS
55
3
EMR
64
5
SE
49
2
TGNA
53
-3
HAL
50
2
HD
28
-4
Financhill
Back

Inhibrx Biosciences, Inc. 10K Form

Buy
65

INBX
Inhibrx Biosciences, Inc.

Last Price:
$86.43
Seasonality Move:
-3.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBX News And Ratings

See the #1 stock for the next 7 days that we like better than INBX

INBX Financial Statistics

Sales & Book Value

Annual Sales: $200K
Cash Flow: $-33.8M
Price / Cash Flow: 0
Annual Sales: $2.54
Price / Book: 33.85

Profitability

EPS (TTM): -10.23680
Net Income (TTM): $-155.1M
Gross Margin: $-2.1M
Return on Equity: -151.49%
Return on Assets: -74.88%

Inhibrx Biosciences, Inc. Earnings Forecast

Key Inhibrx Biosciences, Inc. Financial Ratios

  • The Gross Profit Margin over the past 3 years for INBX is -1,042.50%.
  • The Selling, General & Administrative Expenses for INBX have been equal to 63,952.50% of Gross Profit Margin.
  • The Research & Development expenses have been 100,931.00% of Revenue.
  • The Interest Expense is 0.80% of Operating Income.
  • The Net Earning history of INBX is 843,786.00% of Total Revenues.
  • Per Share Earnings over the last 3 years have been positive in 1 years.

Inhibrx Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INBX
Website: inhibrx.com

Debt

Debt-to-Equity Ratio: 2.9
Current Ratio: 4.49
Quick Ratio: 4.26

Price-to-Earnings

Trailing P/E Ratio: 0.74
Forward P/E Ratio: 0

INBX Technical Analysis vs Fundamental Analysis

Buy
65
Inhibrx Biosciences, Inc. (INBX) is a Buy

Is Inhibrx Biosciences, Inc. a Buy or a Sell?